UBS Group AG cut its stake in shares of abrdn Healthcare Investors (NYSE:HQH – Free Report) by 21.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 124,182 shares of the financial services provider’s stock after selling 34,669 shares during the quarter. UBS Group AG owned about 0.23% of abrdn Healthcare Investors worth $2,352,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Shaker Financial Services LLC bought a new position in shares of abrdn Healthcare Investors during the fourth quarter valued at $408,000. Vista Investment Partners II LLC increased its holdings in shares of abrdn Healthcare Investors by 17.4% during the fourth quarter. Vista Investment Partners II LLC now owns 13,154 shares of the financial services provider’s stock valued at $249,000 after acquiring an additional 1,950 shares in the last quarter. Flagship Harbor Advisors LLC bought a new position in shares of abrdn Healthcare Investors during the fourth quarter valued at $48,000. Uhlmann Price Securities LLC increased its holdings in shares of abrdn Healthcare Investors by 3.1% during the fourth quarter. Uhlmann Price Securities LLC now owns 25,711 shares of the financial services provider’s stock valued at $487,000 after acquiring an additional 781 shares in the last quarter. Finally, Advisory Services Network LLC bought a new position in shares of abrdn Healthcare Investors during the third quarter valued at $97,000. 32.60% of the stock is currently owned by institutional investors.
abrdn Healthcare Investors Stock Performance
Shares of NYSE:HQH opened at $19.47 on Thursday. abrdn Healthcare Investors has a 1-year low of $15.09 and a 1-year high of $20.46. The business has a fifty day moving average price of $19.15 and a 200-day moving average price of $19.08.
abrdn Healthcare Investors Announces Dividend
abrdn Healthcare Investors Company Profile
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Further Reading
- Five stocks we like better than abrdn Healthcare Investors
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for abrdn Healthcare Investors (NYSE:HQH – Free Report).
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
